Economic Evaluation of Vaccines: Belgian Reflections on the Need for a Broader Perspective

Innate immune memory of tissue‐resident macrophages and trained innate immunity: Re‐vamping vaccine concept and strategies

(2020) Zhou Xing et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Differences in Health Technology Assessment Recommendations Among European Jurisdictions: The Role of Practice Variations

(2020) Rick A. Vreman et al.   VALUE IN HEALTH

Indirect costs of adult pneumococcal disease and the productivity-based rate of return to the 13-valent pneumococcal conjugate vaccine for adults in Turkey

(2020) J. P. Sevilla et al.   Human Vaccines & Immunotherapeutics

Advances in Targeting the Innate and Adaptive Immune Systems to Cure Chronic Hepatitis B Virus Infection

(2020) Zhongji Meng et al.   Frontiers in Immunology

Innate and secondary humoral responses are improved by increasing the time between MVA vaccine immunizations

(2020) Jean-Louis Palgen et al.   npj Vaccines

Network multipliers and public health

(2019) Tyler J VanderWeele et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Quantifying the public's view on social value judgments in vaccine decision-making: A discrete choice experiment

(2019) Jeroen Luyten et al.   SOCIAL SCIENCE & MEDICINE

Factors associated with chronic obstructive pulmonary disease exacerbation, based on big data analysis

(2019) Jongmin Lee et al.   Scientific Reports

Innate sensors that regulate vaccine responses

(2019) Philipp Georg et al.   CURRENT OPINION IN IMMUNOLOGY

Rotavirus-Induced Neonatal Epileptic Encephalopathy—A Disease Spectrum Illustrated by Monochorionic Twins

(2019) Esther M. Hopmans et al.   NEUROPEDIATRICS

Pneumococcal Disease: A Systematic Review of Health Utilities, Resource Use, Costs, and Economic Evaluations of Interventions

(2019) Tinevimbo Shiri et al.   VALUE IN HEALTH

The Epidemiology of Herpes Zoster in Immunocompetent, Unvaccinated Adults ≥50 Years Old: Incidence, Complications, Hospitalization, Mortality, and Recurrence

(2019) Hung Fu Tseng et al.   JOURNAL OF INFECTIOUS DISEASES

Liver transplantation vs liver resection in patients with HBV-related hepatocellular carcinoma beyond Milan criterion: A meta-analysis

(2018) Wei Li et al.   CLINICAL TRANSPLANTATION

Distributional cost-effectiveness analysis in low- and middle-income countries: illustrative example of rotavirus vaccination in Ethiopia

(2018) Bryony R Dawkins et al.   HEALTH POLICY AND PLANNING

Use of mathematical modelling to assess the impact of vaccines on antibiotic resistance

(2018) Katherine E Atkins et al.   LANCET INFECTIOUS DISEASES

The broad socioeconomic benefits of vaccination

(2018) David E. Bloom et al.   Science Translational Medicine

Approaches to Aggregation and Decision Making—A Health Economics Approach: An ISPOR Special Task Force Report [5]

(2018) Charles E. Phelps et al.   VALUE IN HEALTH

Defining Elements of Value in Health Care—A Health Economics Approach: An ISPOR Special Task Force Report [3]

(2018) Darius N. Lakdawalla et al.   VALUE IN HEALTH

Influenza vaccination and prevention of antimicrobial resistance

(2018) Susanna Esposito et al.   Expert Review of Vaccines

Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: implications for adult vaccination

(2018) Germaine Hanquet et al.   THORAX

Economic Analysis of Vaccination Programs: An ISPOR Good Practices for Outcomes Research Task Force Report

(2018) Josephine Mauskopf et al.   VALUE IN HEALTH

Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017

(2018) Christopher E Troeger et al.   Lancet Respiratory Medicine

Family Spillover Effects in Pediatric Cost-Utility Analyses

(2018) Tara A. Lavelle et al.   Applied Health Economics and Health Policy

Spillover effects in epidemiology: parameters, study designs and methodological considerations

(2017) Jade Benjamin-Chung et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Moving beyond traditional valuation of vaccination: Needs and opportunities

(2017) David E. Bloom et al.   VACCINE

Variation in Health Technology Assessment and Reimbursement Processes in Europe

(2017) Ronald L Akehurst et al.   VALUE IN HEALTH

The Social Value Of Vaccination Programs: Beyond Cost-Effectiveness

(2016) Jeroen Luyten et al.   HEALTH AFFAIRS

Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial

(2016) Stéphane Verguet et al.   PHARMACOECONOMICS

Total Economic Consequences of an Influenza Outbreak in the United States

(2016) Fynnwin Prager et al.   RISK ANALYSIS

Heterologous vaccine effects

(2016) Mitra Saadatian-Elahi et al.   VACCINE

Vaccinating Italian infants with a new multicomponent vaccine (Bexsero®) against meningococcal B disease: A cost-effectiveness analysis

(2016) Roberto Gasparini et al.   Human Vaccines & Immunotherapeutics

Caregiving and Its Resulting Effects—The Care Study to Evaluate the Effects of Caregiving on Caregivers of Patients with Advanced Cancer in Singapore

(2016) Cheryl Chua et al.   Cancers

European collaboration on relative effectiveness assessments: What is needed to be successful?

(2015) Sarah Kleijnen et al.   HEALTH POLICY

Distributional Cost-Effectiveness Analysis

(2015) Miqdad Asaria et al.   MEDICAL DECISION MAKING

Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community

(2015) Bernhard Ultsch et al.   PHARMACOECONOMICS

Valuing vaccines: Deficiencies and remedies

(2015) David E. Bloom   VACCINE

Public Preferences for Prioritizing Preventive and Curative Health Care Interventions: A Discrete Choice Experiment

(2015) Jeroen Luyten et al.   VALUE IN HEALTH

Attributes and weights in health care priority setting: A systematic review of what counts and to what extent

(2015) Yuanyuan Gu et al.   SOCIAL SCIENCE & MEDICINE

Influenza-Like-Illness and Clinically Diagnosed Flu: Disease Burden, Costs and Quality of Life for Patients Seeking Ambulatory Care or No Professional Care at All

(2014) Joke Bilcke et al.   PLoS One

Valuing vaccination

(2014) T. Barnighausen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Cost-effectiveness of seasonal influenza vaccination in pregnant women, health care workers and persons with underlying illnesses in Belgium

(2014) Adriaan Blommaert et al.   VACCINE

Varicella-zoster virus vaccination under the exogenous boosting hypothesis: Two ethical perspectives

(2014) Jeroen Luyten et al.   VACCINE

Reassessing the value of vaccines

(2014) Till Bärnighausen et al.   Lancet Global Health

Childhood varicella-zoster virus vaccination in Belgium: Cost-effective only in the long run or without exogenous boosting?

(2013) Joke Bilcke et al.   Human Vaccines & Immunotherapeutics

The Impact of Rotavirus Vaccination on Discounted Net Tax Revenue in Egypt

(2012) Mark P. Connolly et al.   PHARMACOECONOMICS

On Discounting of Health Gains from Human Papillomavirus Vaccination: Effects of Different Approaches

(2012) Tjalke A. Westra et al.   VALUE IN HEALTH

Public preferences over efficiency, equity and autonomy in vaccination policy: An empirical study

(2012) Jeroen Luyten et al.   SOCIAL SCIENCE & MEDICINE

Clinical and economic burden of community-acquired pneumonia among adults in Europe

(2010) T Welte et al.   THORAX

HEALTH-RELATED QUALITY OF LIFE LOST TO ROTAVIRUS-ASSOCIATED GASTROENTERITIS IN CHILDREN AND THEIR PARENTS

(2009) Marc Brisson et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

The economic impact of SARS in Beijing, China

(2009) Philippe Beutels et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

WHO Guide for standardisation of economic evaluations of immunization programmes

(2009) Damian G. Walker et al.   VACCINE

Partially wrong? Partial equilibrium and the economic analysis of public health emergencies of international concern

(2008) P. Beutels et al.   HEALTH ECONOMICS

The economic impact of SARS: How does the reality match the predictions?

(2008) Marcus Richard Keogh-Brown et al.   HEALTH POLICY

Funding of drugs: do vaccines warrant a different approach?

(2008) Philippe Beutels et al.   LANCET INFECTIOUS DISEASES

Cost-Effectiveness of Rotavirus Vaccination: Exploring Caregiver(s) and ``No Medical Care'' Disease Impact in Belgium

(2008) Joke Bilcke et al.   MEDICAL DECISION MAKING